|
Research & Development
|
0.51M | | 0.65M | 2.62M |
|
Selling, General & Administrative
|
0.59M | | 2.77M | 7.12M |
|
Other Operating Expenses
|
0.00 | 1.67M | | 15.34M |
|
Operating Expenses
|
1.10M | 1.67M | 3.42M | 9.74M |
|
Operating Income
|
-1.10M | -1.67M | -3.42M | -9.74M |
|
EBIT
|
-1.10M | -1.67M | -3.42M | -9.74M |
|
Interest & Investment Income
|
-0.06M | 5.22M | -0.12M | 0.09M |
|
Other Non Operating Income
|
0.22M | 6.16M | -3.21M | -0.53M |
|
Non Operating Income
|
0.22M | 11.38M | -2.62M | 13.47M |
|
EBT
|
-0.93M | 9.71M | -6.04M | 3.73M |
|
Tax Provisions
|
| 1.10M | | |
|
Profit After Tax
|
-0.93M | 8.61M | -6.04M | 3.73M |
|
Income from Continuing Operations
|
-0.93M | 8.61M | -6.04M | 3.73M |
|
Consolidated Net Income
|
-0.93M | 8.61M | -6.04M | 3.73M |
|
Income towards Parent Company
|
-0.93M | 8.61M | -6.04M | 3.73M |
|
Net Income towards Common Stockholders
|
-0.93M | 8.61M | -6.04M | 3.73M |
|
EPS (Basic)
|
-0.13 | 0.55 | -0.56 | 0.14 |
|
EPS (Weighted Average and Diluted)
|
-0.13 | | -0.56 | 0.12 |
|
Shares Outstanding (Weighted Average)
|
17.10M | | 18.22M | 31.39M |
|
EBITDA
|
-1.10M | -1.67M | -3.42M | -9.74M |
|
Tax Rate
|
| 11.28 | | |